During the past decade, Arkansas Heart Hospital conducted 40 clinical trials. In the 10-year time frame, 40 clinical trials started and 32 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 18 clinical trials were completed. i.e. 128.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Arkansas Heart Hospital" #1 sponsor was "Abbott Medical Devices" with 31 trials, followed by "Arkansas Heart Hospital" with 6 trials sponsored, "Boston Scientific Corporation" with 6 trials sponsored, "Mercator MedSystems, Inc." with 5 trials sponsored and "Cardiovascular Systems Inc" with 5 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Arkansas Heart Hospital" #1 collaborator was "Abbott" with 2 trials as a collaborator, "Baim Institute for Clinical Research" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Daiichi Sankyo, Inc." with 2 trials as a collaborator and "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Arkansas Heart Hospital" are "Coronary Artery Disease" (15 trials), "Peripheral Arterial Disease" (12 trials), "Heart Failure" (8 trials), "Coronary Disease" (4 trials) and "Bradycardia" (3 trials). Many other conditions were trialed in "Arkansas Heart Hospital" in a lesser frequency.

Most popular intervention types in "Arkansas Heart Hospital" are "Device" (58 trials), "Drug" (15 trials), "Other" (6 trials), "Procedure" (5 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "XIENCE" (4 trials), "Absorb BVS" (2 trials), "Aspirin" (2 trials), "Balloon Angioplasty" (2 trials) and "Esprit BTK Device" (2 trials). Other intervention names were less common.

The vast majority of trials in "Arkansas Heart Hospital" are 74 trials for "All" genders.

Currently, there are NaN active trials in "Arkansas Heart Hospital". undefined are not yet recruiting, 3 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 44 completed trials in Arkansas Heart Hospital, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Arkansas Heart Hospital, 2 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 35 trials that are defined as “Not Applicable".

Arkansas Heart Hospital has several departments that took part in Clinical trials: "Arrhythmia Research Group" - 17 trials, "Arkansas Heart Hospital Clinic" - 6 trials